Cure Ventures backs a cell therapy startup targeting Parkinson's
BioPharma
Source: biopharmadive.com
Page 3 - Column Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Column Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Column Group Today - Breaking & Trending Today
Kenai Therapeutics Announces 82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases
Kenai Therapeutics a biotechnology company leveraging induced pluripotent stem cell iPSC technology to discover and develop a platform of allogeneic neuron replacement cell therapies for neurological disorders today announced an 82 million Series A financing coled by Alaska Permanent Fund Corporation Cure Ventures and The Column Group with participation from Euclidean Capital and Saisei Ventures.
Source: businesswireindia.com
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - AA, NGM, MDC, KAMN -February 26, 2024 at 07:45 pm EST
NEW YORK, Feb. 26, 2024 /PRNewswire/ -- Monteverde & Associates PC , has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services...
Source: marketscreener.com
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates NGM, AA, HRT, KNTE
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Source: prnewswire.com
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates NGM, AA, HRT, KNTE -February 26, 2024 at 10:16 pm EST
NEW YORK, Feb. 26, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Source: marketscreener.com